Heart attack

Combinatorial therapy for Myocardial Infarction: A combination of Rivaroxaban and Asprin (RA) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up regulation of PNUTS, 27/October/2017, 12.20 am
Combinatorial therapy for Myocardial Infarction: A combination of Rivaroxaban and Asprin (RA) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up regulation of PNUTS, 27/October/2017, 12.20 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of Nature,  by Prof Dimmler, Boon, and others. Further, a recent…

read more

Natural product-derived therapy for attenuating pathogenesis of Myocardial infarction: Glabridin, found abundantly in licorice (Glycyrrhiza glabra), decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 25/October/2017, 11.53 pm
Natural product-derived therapy for attenuating pathogenesis of Myocardial infarction: Glabridin, found abundantly in licorice (Glycyrrhiza glabra), decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 25/October/2017, 11.53 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A recent study from Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; and Center for Systems Biology, Massachusetts General Hospital…

read more

Molecular therapy for heart regeneration and repair: A pharmaceutical mixture encompassing Rivaroxaban and Asprin (RA) increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 25/October/2017, 11.40 pm
Molecular therapy for heart regeneration and repair: A pharmaceutical mixture encompassing Rivaroxaban and Asprin (RA) increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 25/October/2017, 11.40 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708, USA;…

read more

Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: A pharmaceutical mixture encompassing Rivaroxaban and Asprin (RA) increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down regulation of its target gene, 24/October/2017, 11.24 pm
Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: A pharmaceutical mixture encompassing Rivaroxaban and Asprin (RA) increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down regulation of its target gene, 24/October/2017, 11.24 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was published, in the 6 April  2015…

read more

Natural product-based therapy for Cardiomyopathy: Aspalathin, found abundantly in Rooibos/Aspalathus linearis, decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 24/October/2017,  10.42 pm
Natural product-based therapy for Cardiomyopathy: Aspalathin, found abundantly in Rooibos/Aspalathus linearis, decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 24/October/2017,  10.42 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A recent study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart function through microRNA-mediated Sox6 repression.” This…

read more

Natural product-derived therapy for Myocardial Infarction: Osthole, an O-methylated coumarin isolated from Cnidium monnieri, Angelica archangelica &  Angelica pubescens,  inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via  up-regulation of PNUTS, 02/October/2017, 11.30 pm
Natural product-derived therapy for Myocardial Infarction: Osthole, an O-methylated coumarin isolated from Cnidium monnieri, Angelica archangelica &  Angelica pubescens,  inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via  up-regulation of PNUTS, 02/October/2017, 11.30 pm 960 720 Dr Boomi's Genom-2-Discovery Center

On the eve of Mahatma Gandhi Birth Anniversary ********* We wish everyone a happy Mahatma Gandhi Jayanti 2017. On this special occasion, we are happy to announce that Ideas posted today (02/October/2017) will be available to the…

read more
Start Typing